These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 10075157)

  • 21. Chronic local tissue reactions, long-term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers.
    Gupta RK; Alroy J; Alonso MJ; Langer R; Siber GR
    Vaccine; 1997 Nov; 15(16):1716-23. PubMed ID: 9364673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties.
    Morlock M; Kissel T; Li YX; Koll H; Winter G
    J Control Release; 1998 Dec; 56(1-3):105-15. PubMed ID: 9801434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen.
    Challacombe SJ; Rahman D; Jeffery H; Davis SS; O'Hagan DT
    Immunology; 1992 May; 76(1):164-8. PubMed ID: 1628895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies.
    Eldridge JH; Staas JK; Meulbroek JA; Tice TR; Gilley RM
    Infect Immun; 1991 Sep; 59(9):2978-86. PubMed ID: 1879922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of solvent selection and fabrication method on the characteristics of biodegradable poly(lactide-co-glycolide) microspheres containing ovalbumin.
    Cho SW; Song SH; Choi YW
    Arch Pharm Res; 2000 Aug; 23(4):385-90. PubMed ID: 10976588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new method for preparing biodegradable microparticles and entrapment of hydrocortisone in DL-PLG microparticles using supercritical fluids.
    Ghaderi R; Artursson P; Carlfors J
    Eur J Pharm Sci; 2000 Mar; 10(1):1-9. PubMed ID: 10699378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of hepatitis B oral vaccine using B-cell epitope loaded PLG microparticles.
    Rajkannan R; Dhanaraju MD; Gopinath D; Selvaraj D; Jayakumar R
    Vaccine; 2006 Jun; 24(24):5149-57. PubMed ID: 16713035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intranasal immunization of BALB/c mice with enterotoxigenic Escherichia coli colonization factor CS6 encapsulated in biodegradable poly(DL-lactide-co-glycolide) microspheres.
    Byrd W; Cassels FJ
    Vaccine; 2006 Feb; 24(9):1359-66. PubMed ID: 16233937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation: particle size study.
    Uchida T; Goto S
    Biol Pharm Bull; 1994 Sep; 17(9):1272-6. PubMed ID: 7841952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intranasal vaccination with poly(lactide-co-glycolide) microparticles containing a peptide T of Ole e 1 prevents mice against sensitization.
    Marazuela EG; Prado N; Moro E; Fernández-García H; Villalba M; Rodríguez R; Batanero E
    Clin Exp Allergy; 2008 Mar; 38(3):520-8. PubMed ID: 18205856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formulation of L-asparaginase-loaded poly(lactide-co-glycolide) nanoparticles: influence of polymer properties on enzyme loading, activity and in vitro release.
    Gasper MM; Blanco D; Cruz ME; Alonso MJ
    J Control Release; 1998 Mar; 52(1-2):53-62. PubMed ID: 9685935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral immunization with Helicobacter pylori-loaded poly(D, L-lactide-co-glycolide) nanoparticles.
    Kim SY; Doh HJ; Jang MH; Ha YJ; Chung SI; Park HJ
    Helicobacter; 1999 Mar; 4(1):33-9. PubMed ID: 10352085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation of biodegradable microparticles using solution-enhanced dispersion by supercritical fluids (SEDS).
    Ghaderi R; Artursson P; Carlfors J
    Pharm Res; 1999 May; 16(5):676-81. PubMed ID: 10350010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigen-specific IgA and IgG responses in calves inoculated intranasally with ovalbumin encapsulated in poly(DL-lactide-co-glycolide) microspheres.
    Kavanagh OV; Earley B; Murray M; Foster CJ; Adair BM
    Vaccine; 2003 Oct; 21(27-30):4472-80. PubMed ID: 14505930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
    San Román B; Irache JM; Gómez S; Tsapis N; Gamazo C; Espuelas MS
    Eur J Pharm Biopharm; 2008 Sep; 70(1):98-108. PubMed ID: 18501572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gamma irradiation for terminal sterilization of 17beta-estradiol loaded poly-(D,L-lactide-co-glycolide) microparticles.
    Mohr D; Wolff M; Kissel T
    J Control Release; 1999 Aug; 61(1-2):203-17. PubMed ID: 10469916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CTL responses induced by a single immunization with peptide encapsulated in biodegradable microparticles.
    Partidos CD; Vohra P; Jones D; Farrar G; Steward MW
    J Immunol Methods; 1997 Aug; 206(1-2):143-51. PubMed ID: 9328577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlled release of transforming growth factor beta1 from biodegradable polymer microparticles.
    Lu L; Stamatas GN; Mikos AG
    J Biomed Mater Res; 2000 Jun; 50(3):440-51. PubMed ID: 10737887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency.
    Kazzaz J; Singh M; Ugozzoli M; Chesko J; Soenawan E; O'Hagan DT
    J Control Release; 2006 Feb; 110(3):566-73. PubMed ID: 16360956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Encapsulation of antigen in poly(D,L-lactide-co-glycolide) microspheres protects from harmful effects of γ-irradiation as assessed in mice.
    Mohanan D; Gander B; Kündig TM; Johansen P
    Eur J Pharm Biopharm; 2012 Feb; 80(2):274-81. PubMed ID: 22024408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.